Health News

News > Health News

RSS Feed

DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated unprecedented median overall survival improvement of five months vs. chemo as 1st-line treatment for patients with metastatic triple-negative breast cancer for whom immunotherapy was not an option

4:00 AM on Sunday, October 19

DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02

11:30 PM on Saturday, October 18

KEYTRUDA® (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Risk of Disease Progression or Death Versus Chemotherapy With or Without Bevacizumab in Certain Patients With Platinum-Resistant Recurrent Ovarian Cancer

7:35 AM on Saturday, October 18

ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the risk of disease recurrence or death by 53% vs. T-DM1 in patients with high-risk HER2-positive early breast cancer following neoadjuvant therapy in DESTINY-Breast05 Phase III trial

7:35 AM on Saturday, October 18

KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Event-Free Survival Events by 60% and Risk of Death by 50% for Certain Patients with Muscle-Invasive Bladder Cancer When Given Before and After Surgery

7:30 AM on Saturday, October 18

ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery resulted in a pathologic complete response in 67% of patients with high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11 Phase III trial

7:30 AM on Saturday, October 18

ENHERTU® Reduced the Risk of Disease Recurrence or Death by 53% Versus T-DM1 in Patients with High-Risk HER2 Positive Early Breast Cancer Following Neoadjuvant Therapy in DESTINY-Breast05 Phase 3 Trial

7:30 AM on Saturday, October 18

Nurse Rod Salaysay plays guitar for patient Richard Hoang in the recovery unit of UC San Diego Health in San Diego, Calif., on Sept. 30, 2025. (AP Photo/Javier Arciga)

Music could help ease pain from surgery or illness. Scientists are listening

6:04 AM on Saturday, October 18

Hospitals and doctors' offices are inviting singers and musicians to help patients manage their pain, as music's ability to reduce pain is gaining attention

Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 2025

4:00 AM on Saturday, October 18

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen

3:00 AM on Saturday, October 18

Third-floor balcony in Cincinnati collapses, sending 10 people to the hospital

9:12 PM on Friday, October 17

Officials say a balcony on the third floor of a building near the University of Cincinnati has collapsed, sending 10 people to the hospital

First ... 24 25 26 27 28 ... Last

Salem News Channel Today

Sponsored Links

On Air & Up Next

  • The Chris Stigall Show
    3:00AM - 6:00AM
     
    Equal parts hilarity and desk-pounding monologues with healthy doses of skepticism and sarcasm.
     
  • The Mike Gallagher Show
    6:00AM - 9:00AM
     
    Mike Gallagher is one of the most listened-to radio talk show hosts in America.   >>
     
  • The Charlie Kirk Show
    9:00AM - 11:00AM
     
    "The Charlie Kirk Show" can be heard weekdays across Salem Radio Network and watched on The Salem News Channel.
     
  • The O'Reilly Update
    10:00AM - 10:06AM
     
    Americans need real reporting, honest analysis, and straight talk now more than   >>
     
  • The O'Reilly Update
    11:00AM - 11:06AM
     
    Americans need real reporting, honest analysis, and straight talk now more than   >>
     

See the Full Program Guide